Recent trends in epidemiology of invasive pneumococcal disease in Poland
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Recent trends in epidemiology of invasive pneumococcal disease in Poland
Authors
Keywords
Meningitis, Cefotaxime, Meropenem, Invasive Pneumococcal Disease, Vaccine Coverage
Journal
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
Volume 34, Issue 4, Pages 779-787
Publisher
Springer Nature
Online
2014-12-04
DOI
10.1007/s10096-014-2283-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- National surveillance of invasive pneumococcal diseases in Taiwan, 2008–2012: Differential temporal emergence of serotype 19A
- (2014) Chuen-Sheue Chiang et al. VACCINE
- European enhanced surveillance of invasive pneumococcal disease in 2010: Data from 26 European countries in the post-heptavalent conjugate vaccine era
- (2014) Adoración Navarro Torné et al. VACCINE
- Pneumococcal Serotype Diversity Among Adults in Various Countries, Influenced by Pediatric Pneumococcal Vaccination Uptake
- (2013) J. D. Grabenstein et al. CLINICAL INFECTIOUS DISEASES
- A Decade of Invasive Meningococcal Disease Surveillance in Poland
- (2013) Anna Skoczyńska et al. PLoS One
- Serotype prevalence and antibiotic resistance in Streptococcus pneumoniae clinical isolates among global populations
- (2013) M. Hackel et al. VACCINE
- Effect of Serotype on Focus and Mortality of Invasive Pneumococcal Disease: Coverage of Different Vaccines and Insight into Non-Vaccine Serotypes
- (2012) Albert Jan van Hoek et al. PLoS One
- Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
- (2011) A.-P. Magiorakos et al. CLINICAL MICROBIOLOGY AND INFECTION
- Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study
- (2011) Elizabeth Miller et al. LANCET INFECTIOUS DISEASES
- Significant decline in pneumonia admission rate after the introduction of routine 2+1 dose schedule heptavalent pneumococcal conjugate vaccine (PCV7) in children under 5 years of age in Kielce, Poland
- (2010) M. Patrzałek et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Serotype 19A Is the Most Common Serotype Causing Invasive Pneumococcal Infections in Children
- (2010) S. L. Kaplan et al. PEDIATRICS
- The current status of invasive pneumococcal disease in Poland
- (2010) Anna Skoczyńska et al. VACCINE
- Emergence of Streptococcus pneumoniae of serotype 19A in France: molecular capsular serotyping, antimicrobial susceptibilities, and epidemiology
- (2009) Laurent Dortet et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Current knowledge regarding the investigational 13-valent pneumococcal conjugate vaccine
- (2009) Ener Cagri Dinleyici et al. Expert Review of Vaccines
- Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines
- (2009) Daniel J. Isaacman et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates
- (2009) Katherine L O'Brien et al. LANCET
- Effect of Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis
- (2009) Heather E. Hsu et al. NEW ENGLAND JOURNAL OF MEDICINE
- National survey of invasive pneumococcal diseases in Taiwan under partial PCV7 vaccination in 2007: Emergence of serotype 19A with high invasive potential
- (2009) Yu-Chia Hsieh et al. VACCINE
- Impact of conjugate pneumococcal vaccines on antibiotic resistance
- (2008) Ron Dagan et al. LANCET INFECTIOUS DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation